VIR,ZM Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.30
Percentage change 5.83	%

Peers: REGN MRNA LLY PFE JNJ GILD BNTX AZN SNY NVAX

| Held by: IJR VTI VB IWM XBI VBK VXF IJS IWN SPSM

Index	RUT	P/E	-	EPS (ttm)	-4.22	Insider Own	35.56%	Shs Outstand	138.06M	Perf Week	10.32%
Market Cap	753.40M	Forward P/E	-	EPS next Y	-3.08	Insider Trans	-0.33%	Shs Float	89.08M	Perf Month	-2.85%
Income	-577.65M	PEG	-	EPS next Q	-0.74	Inst Own	53.56%	Short Float	12.28%	Perf Quarter	-31.53%
Sales	20.86M	P/S	36.12	EPS this Y	16.37%	Inst Trans	6.07%	Short Ratio	8.08	Perf Half Y	-40.76%
Book/sh	7.56	P/B	0.72	EPS next Y	3.70%	ROA	-37.25%	Short Interest	10.94M	Perf Year	-48.49%
Cash/sh	6.44	P/C	0.85	EPS next 5Y	10.19%	ROE	-44.59%	52W Range	4.32 - 14.45	Perf YTD	-25.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-18.74%	ROI	-51.03%	52W High	-62.28%	Beta	1.23
Dividend TTM	-	Quick Ratio	6.79	Sales past 5Y	55.77%	Gross Margin	34.35%	52W Low	26.16%	ATR (14)	0.32
Dividend Ex-Date	Nov 03, 2010	Current Ratio	6.79	EPS Y/Y TTM	-5.24%	Oper. Margin	-2796.93%	RSI (14)	55.31	Volatility	3.45% 4.76%
Employees	408	Debt/Eq	0.09	Sales Y/Y TTM	-73.79%	Profit Margin	-2769.04%	Recom	1.56	Target Price	17.88
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	-82.36%	Payout	-	Rel Volume	0.98	Prev Close	5.15
Sales Surprise	-64.71%	EPS Surprise	-5.30%	Sales Q/Q	-94.62%	Earnings	May 07 AMC	Avg Volume	1.35M	Price	5.45
SMA20	11.85%	SMA50	-0.51%	SMA200	-28.43%	Trades		Volume	1,332,434	Change	5.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-29-24	Downgrade	JP Morgan	Overweight → Neutral	$23 → $9
Sep-08-23	Downgrade	BofA Securities	Buy → Neutral	$23 → $14
Mar-06-23	Upgrade	JP Morgan	Neutral → Overweight	$35 → $34
Feb-21-23	Upgrade	Goldman	Neutral → Buy	$41 → $53
Jan-27-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$18 → $30
Sep-14-22	Initiated	SVB Leerink	Outperform	$40
Sep-09-22	Initiated	Morgan Stanley	Underweight	$15
Mar-03-22	Upgrade	Robert W. Baird	Underperform → Neutral	$36 → $28
Dec-21-21	Downgrade	Robert W. Baird	Neutral → Underperform	$36
Oct-25-21	Upgrade	JP Morgan	Underweight → Neutral	$29 → $37
Sep-22-21	Downgrade	Goldman	Buy → Neutral	$64 → $62
Jun-04-21	Resumed	Robert W. Baird	Neutral	$45
Jan-27-21	Downgrade	JP Morgan	Neutral → Underweight	$30
Jan-20-21	Reiterated	H.C. Wainwright	Buy	$100 → $125
Oct-05-20	Initiated	BofA Securities	Buy	$55
Sep-14-20	Upgrade	Goldman	Neutral → Buy	$48 → $54
Sep-11-20	Upgrade	JP Morgan	Underweight → Neutral	$29
Aug-20-20	Initiated	Needham	Buy	$62
Mar-19-20	Downgrade	JP Morgan	Neutral → Underweight	$26
Mar-13-20	Downgrade	Goldman	Buy → Neutral

Show Previous Ratings

May-28-25 04:05PM	Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire) +9.03%
May-20-25 04:05PM	Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit (Business Wire)
May-12-25 04:05PM	Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference (Business Wire) -11.32%
May-09-25 06:00AM	Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study (Business Wire) -6.01%
May-08-25 09:35AM	Q1 2025 Vir Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
03:31AM	Loading…
03:31AM	Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-07-25 11:21PM	Vir Biotechnology announces initiation of ECLIPSE Phase III program for hepatitis delta virus (Seeking Alpha)
11:21PM	Vir Biotechnology, Inc. (VIR) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:15PM	Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results (Business Wire)
Apr-30-25 04:05PM	Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
11:45AM	GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance (Zacks)
Apr-24-25 09:30AM	Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025 (Business Wire) +5.36%
Apr-09-25 09:43AM	Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple (Insider Monkey) +10.21%
Mar-30-25 03:50AM	abrdn Life Sciences Investors Q4 2024 Commentary (Seeking Alpha)
02:50AM	Loading…
02:50AM	abrdn Healthcare Investors Q4 2024 Commentary (Seeking Alpha)
Mar-21-25 07:10AM	Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results (PR Newswire)
Mar-13-25 08:05AM	Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta (Business Wire)
Feb-27-25 01:30PM	Q4 2024 Vir Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents) -11.85%
02:24AM	Vir Biotechnology Inc (VIR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com)
Feb-26-25 05:45PM	Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-19-25 04:05PM	Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-12-25 04:05PM	Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 (Business Wire) +5.16%
Jan-23-25 06:35PM	Why Vir Biotechnology, Inc. (VIR) Is Skyrocketing Now (Insider Monkey) +6.36% -5.09%
Jan-10-25 02:32PM	Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why (Benzinga)
Jan-09-25 08:30AM	Morgan Stanley upgrades Vir Biotechnology to 'overweight,' raises PT to $20 (Investing.com)
08:18AM	Vir Biotechnology Reports Promising Trial Results for Cancer Therapies (TipRanks)
Jan-08-25 04:06PM	Vir Biotechnology Catapults 58% On Promising Results In Cancer Treatment (Investor's Business Daily) +58.17%
07:45AM	Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC (Business Wire)
07:25AM	Loading…
07:25AM	Vir Biotechnology price target lowered to $14 from $15 at BofA (TipRanks)
Dec-18-24 09:30AM	Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-12-24 04:05PM	Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta (Business Wire)
Dec-03-24 04:07PM	Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride (Investor's Business Daily) +12.88% -8.97%
09:02AM	Janux, Vir Catapult On 'Unprecedented' Results In Prostate Cancer Patients (Investor's Business Daily)
Nov-26-24 09:30AM	Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN Masked T-Cell Engager Programs (Business Wire)
Nov-25-24 09:30AM	Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-18-24 09:15PM	Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program (Business Wire) -12.23%
04:05PM	Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency (Business Wire)
Nov-15-24 01:39PM	What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? (Benzinga) -7.29%
11:00AM	Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting (Business Wire)
Nov-01-24 05:01PM	Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ... (GuruFocus.com) +23.63%
12:04AM	U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners (The Wall Street Journal)
Oct-31-24 05:20PM	Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update (Business Wire)
Oct-18-24 03:04PM	State Street Corp's Strategic Acquisition in Vir Biotechnology Inc (GuruFocus.com)
Oct-17-24 04:30PM	Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024 (Business Wire)
Oct-15-24 08:16AM	Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLDs The Liver Meeting 2024 (Business Wire)
Oct-03-24 04:00PM	Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference (Business Wire) +5.59%
Sep-10-24 08:05AM	Vir Biotechnology Appoints Jason OByrne as Chief Financial Officer (Business Wire)
Sep-09-24 04:05PM	Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers (Business Wire)
Sep-04-24 08:30AM	Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 (GlobeNewswire)
Aug-22-24 08:05AM	Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-06-24 09:55AM	Wall Street Analysts See a 258.38% Upside in Vir Biotechnology (VIR): Can the Stock Really Move This High? (Zacks)
Aug-01-24 05:50PM	Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.34%
04:02PM	Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities (Business Wire)
04:01PM	Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers (Business Wire)
Jul-18-24 04:05PM	Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire)
Jul-04-24 10:01AM	3 Undervalued Biotech Gems With 200%+ Analyst Price Targets (InvestorPlace)
Jun-26-24 08:05AM	Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection (Business Wire)
Jun-06-24 01:26PM	Vir Biotechnology (VIR) Up on Positive Data From HDV Study (Zacks) -5.37%
Jun-05-24 02:51PM	Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday? (Benzinga) +19.66%
05:30AM	Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment (Business Wire)
May-29-24 04:05PM	Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire) -5.87%
08:05AM	Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer (Business Wire)
May-23-24 04:05PM	Vir Biotechnology to Host 2024 Annual Meeting of Stockholders (Business Wire) -6.33%
May-22-24 08:05AM	Multiple Abstracts Highlighting Vir Biotechnologys Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024 (Business Wire) +11.36%
May-21-24 08:17AM	Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024 (Business Wire) +5.37%
May-13-24 07:21PM	Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies (PR Newswire)
May-09-24 10:46AM	Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 09:55AM	Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet (Zacks)
May-03-24 01:05PM	Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript (Insider Monkey) +13.18%
06:05AM	Q1 2024 Vir Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
04:06AM	Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-02-24 09:56PM	VIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024 (InvestorPlace) +5.03%
06:05PM	Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 04:05PM	Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024 (Business Wire)
Apr-24-24 12:00PM	What Makes Vir Biotechnology (VIR) a New Buy Stock (Zacks)
Apr-18-24 08:00AM	Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (Business Wire)
Apr-11-24 04:30PM	Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 (Business Wire)
Apr-04-24 07:01PM	Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares (GuruFocus.com)
Mar-22-24 07:00AM	Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results (PR Newswire)
Mar-19-24 02:58PM	From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires (InvestorPlace) -6.37%
Mar-13-24 11:07AM	Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio (InvestorPlace)
Mar-05-24 08:05AM	Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule (Business Wire)
Feb-23-24 01:54PM	Q4 2023 Vir Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents) +11.94%
10:34AM	Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:55AM	Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade (Zacks)
08:05AM	Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences (Business Wire)
Feb-22-24 05:50PM	Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:30PM	Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer (Business Wire)
Feb-14-24 03:45PM	3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave (InvestorPlace) +10.62%
Feb-01-24 04:05PM	Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024 (Business Wire)
Jan-15-24 11:32AM	Vir Biotechnology (VIR) Gains 21.7% in 3 Months: Here's Why (Zacks)
Dec-17-23 07:00AM	I See a Vir-y Good Trade (TheStreet.com)
07:00AM	I See a Good Trade on a $10 Biotech Stock (TheStreet.com)
Dec-13-23 04:05PM	Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation (Business Wire) +9.11%
Dec-06-23 04:05PM	Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference (Business Wire)

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Napolitano Janet	Director	Jun 02 '25	Sale	5.05	3,200	16,149	16,416	Jun 02 07:26 PM
JANET ANN NAPOLITANO	Director	Jun 02 '25	Proposed Sale	4.94	3,200	15,808		Jun 02 04:29 PM
De Backer Marianne	Chief Executive Officer	Apr 03 '25	Sale	5.95	79,712	474,239	769,505	Apr 04 04:23 PM
Marianne De Backer	Officer and Director	Apr 03 '25	Proposed Sale	5.95	79,712	474,239		Apr 03 07:50 PM
de Verneuil Vanina	EVP and General Counsel	Feb 26 '25	Sale	9.14	7,373	67,402	79,460	Feb 27 12:39 PM
VANINA DE VERNEUIL	Officer	Feb 26 '25	Proposed Sale	9.10	7,373	67,094		Feb 26 04:23 PM
SCANGOS GEORGE A	Director	Feb 24 '25	Sale	9.45	10,056	95,063	698,239	Feb 25 03:44 PM
HANLY ANN M.	EVP & Chief Technology Officer	Feb 24 '25	Sale	9.45	14,168	133,936	117,901	Feb 25 03:43 PM
Sabatini Brent	SVP, Chief Accounting Officer	Feb 24 '25	Sale	9.45	1,562	14,766	46,627	Feb 25 03:37 PM
De Backer Marianne	Chief Executive Officer	Feb 24 '25	Sale	9.45	16,122	152,408	849,217	Feb 25 03:36 PM
de Verneuil Vanina	EVP and General Counsel	Feb 24 '25	Sale	9.45	5,140	48,590	86,833	Feb 25 03:34 PM
George Scangos	Director	Feb 24 '25	Proposed Sale	9.45	10,056	95,063		Feb 24 08:57 PM
Brent Sabatini	Officer	Feb 24 '25	Proposed Sale	9.45	1,562	14,766		Feb 24 08:57 PM
Ann Hanly	Officer	Feb 24 '25	Proposed Sale	9.45	14,168	133,936		Feb 24 08:56 PM
Vanina de Verneuil	Officer	Feb 24 '25	Proposed Sale	9.45	5,140	48,590		Feb 24 08:40 PM
Marianne De Backer	Officer and Director	Feb 24 '25	Proposed Sale	9.45	16,122	152,408		Feb 24 08:38 PM
SCANGOS GEORGE A	Director	Feb 18 '25	Sale	9.81	10,964	107,575	708,295	Feb 19 07:11 PM
George Scangos	Director	Feb 18 '25	Proposed Sale	9.81	10,964	107,575		Feb 18 07:50 PM
Sabatini Brent	SVP, Chief Accounting Officer	Feb 13 '25	Sale	9.15	1,562	14,291	28,189	Feb 14 06:41 PM
Brent Sabatini	Officer	Feb 13 '25	Proposed Sale	9.15	1,562	14,291		Feb 13 06:49 PM
SATO VICKI L	Director	Jan 08 '25	Sale	12.52	10,960	137,219	1,312,391	Jan 08 08:03 PM
VICKI LEE SATO	Director	Jan 08 '25	Proposed Sale	7.89	43,840	345,898		Jan 08 04:22 PM
de Verneuil Vanina	EVP and General Counsel	Dec 02 '24	Sale	8.22	76	625	56,973	Dec 04 03:35 PM
VANINA ALEXANDRA HUARD DE VERN	Officer	Dec 02 '24	Proposed Sale	8.22	76	625		Dec 02 05:08 PM
de Verneuil Vanina	EVP and General Counsel	Nov 06 '24	Sale	10.11	4,397	44,454	56,973	Nov 07 07:20 PM
VANINA DE VERNEUIL	Officer	Nov 06 '24	Proposed Sale	9.64	4,397	42,387		Nov 06 04:55 PM
de Verneuil Vanina	EVP and General Counsel	Nov 05 '24	Sale	9.47	2,347	22,225	61,370	Nov 05 05:51 PM
de Verneuil Vanina	EVP and General Counsel	Nov 01 '24	Sale	7.20	1,403	10,107	63,717	Nov 05 05:51 PM
VANINA DE VERNEUIL	Officer	Nov 05 '24	Proposed Sale	9.37	2,347	21,991		Nov 05 04:23 PM
Napolitano Janet	Director	Sep 09 '24	Sale	7.80	12,190	95,032	11,616	Sep 10 04:28 PM
JANET ANN NAPOLITANO	Director	Sep 09 '24	Proposed Sale	7.76	12,190	94,594		Sep 09 04:29 PM
Ramasastry Saira	Director	Jun 11 '24	Sale	10.95	4,000	43,789	14,619	Jun 12 12:21 PM

Dollar change -0.98
Percentage change -1.20	%

ZM Zoom Communications Inc daily Stock Chart

Peers: MSFT GOOG GOOGL CRM CSCO ADBE RNG TEAM FIVN LOGI

| Held by: VTI VO VXF VGT VTV COWZ VOE VFLO IGV IWR

Index	-	P/E	24.13	EPS (ttm)	3.33	Insider Own	14.64%	Shs Outstand	261.11M	Perf Week	-1.11%
Market Cap	24.31B	Forward P/E	14.17	EPS next Y	5.67	Insider Trans	-1.64%	Shs Float	258.26M	Perf Month	2.17%
Income	1.05B	PEG	9.61	EPS next Q	1.38	Inst Own	62.60%	Short Float	2.72%	Perf Quarter	5.75%
Sales	4.70B	P/S	5.17	EPS this Y	1.20%	Inst Trans	-0.36%	Short Ratio	2.93	Perf Half Y	-2.76%
Book/sh	29.34	P/B	2.74	EPS next Y	1.17%	ROA	9.87%	Short Interest	7.02M	Perf Year	30.59%
Cash/sh	25.82	P/C	3.11	EPS next 5Y	2.51%	ROE	12.19%	52W Range	55.06 - 92.80	Perf YTD	-1.54%
Dividend Est.	-	P/FCF	14.28	EPS past 5Y	106.45%	ROI	11.73%	52W High	-13.42%	Beta	0.69
Dividend TTM	-	Quick Ratio	4.48	Sales past 5Y	49.60%	Gross Margin	75.85%	52W Low	45.93%	ATR (14)	1.80
Dividend Ex-Date	-	Current Ratio	4.48	EPS Y/Y TTM	24.11%	Oper. Margin	18.13%	RSI (14)	51.68	Volatility	0.83% 1.21%
Employees	7412	Debt/Eq	0.01	Sales Y/Y TTM	2.98%	Profit Margin	22.31%	Recom	2.36	Target Price	90.37
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	18.68%	Payout	0.00%	Rel Volume	0.93	Prev Close	81.33
Sales Surprise	0.72%	EPS Surprise	9.22%	Sales Q/Q	2.93%	Earnings	May 21 AMC	Avg Volume	2.40M	Price	80.35
SMA20	-1.61%	SMA50	4.30%	SMA200	4.30%	Trades		Volume	2,221,621	Change	-1.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-06-25	Initiated	KeyBanc Capital Markets	Underweight
May-22-25	Upgrade	Needham	Hold → Buy	$100
Jan-17-25	Initiated	Cantor Fitzgerald	Neutral	$87
Jan-07-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$70 → $85
Dec-19-24	Upgrade	Jefferies	Hold → Buy	$85 → $100
Nov-26-24	Upgrade	Evercore ISI	In-line → Outperform	$70 → $115
Oct-17-24	Resumed	Wedbush	Outperform	$80 → $85
Apr-18-24	Upgrade	Rosenblatt	Neutral → Buy	$75
Mar-19-24	Initiated	Jefferies	Hold	$70
Jan-18-24	Downgrade	Exane BNP Paribas	Neutral → Underperform	$60
Dec-20-23	Downgrade	Wells Fargo	Equal Weight → Underweight	$70
Nov-17-23	Upgrade	Citigroup	Sell → Neutral	$66
Sep-15-23	Initiated	HSBC Securities	Buy	$83
May-23-23	Upgrade	MoffettNathanson	Underperform → Market Perform	$85
Mar-24-23	Initiated	Rosenblatt	Neutral	$75
Jan-23-23	Downgrade	MKM Partners	Buy → Neutral	$100 → $75
Dec-15-22	Initiated	Wedbush	Neutral	$80
Oct-11-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$130 → $90
Oct-07-22	Downgrade	JP Morgan	Overweight → Neutral	$295 → $85
Sep-23-22	Initiated	Credit Suisse	Neutral	$83

Show Previous Ratings

Jun-07-25 09:40AM	CrowdStrike and McDonalds downgraded: Wall Streets top analyst calls (TipRanks)
Jun-04-25 07:09AM	Guidewire's Q3 Earnings & Revenues Beat Estimates, Stock Surges (Zacks)
May-30-25 11:40AM	Zoom Rises 8% in 3 Months: Here's Why You Should Buy the Stock Now (Zacks)
May-29-25 02:40PM	ZM Q1 Earnings Call: AI Product Expansion and Enterprise Headwinds Shape Outlook (StockStory)
May-28-25 12:00PM	Zoom (ZM) Upgraded to Buy: Here's Why (Zacks)
09:00AM	Loading…
09:00AM	Zoom Communications, Inc. (ZM) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-27-25 11:37PM	Unpacking Q1 Earnings: Zoom (NASDAQ:ZM) In The Context Of Other Video Conferencing Stocks (StockStory)
08:24AM	Safran and Target have been highlighted as Zacks Bull and Bear of the Day (Zacks)
May-26-25 09:15AM	Interpreting Zoom (ZM) International Revenue Trends (Zacks)
May-24-25 08:00AM	Benchmark Raises Zoom Communications (ZM) Price Target to $102 After Q1 Report (Insider Monkey)
06:00AM	Robert W. Baird's Buy on Zoom (ZM) Driven by Innovation-Led Growth (Insider Monkey)
03:22AM	Piper Sandler Lifts Zoom (ZM) Target, Keeps Neutral Rating (Insider Monkey)
May-23-25 05:28PM	Needham Turns Bullish on Zoom (ZM) - The AI Edge That Could Fuel Growth (Insider Monkey)
02:00PM	Whatever Happened to Pandemic Stocks? Some Are Showing Life Again (Zacks)
May-22-25 06:40PM	Closing Bell Movers: Snowflake jumps 7% on earnings (TipRanks)
10:50AM	Loading…
10:50AM	Zoom Q1 Earnings Surpass Expectations, Revenues Increase Y/Y (Zacks)
09:35AM	Stocks to Watch Thursday: TD Bank, Snowflake, Fannie Mae, Urban Outfitters (The Wall Street Journal)
09:22AM	Analyst Report: Zoom Communications Inc. (Morningstar Research)
03:05AM	Zoom Communications Inc (ZM) Q1 2026 Earnings Call Highlights: Revenue Growth and AI Adoption ... (GuruFocus.com)
May-21-25 06:00PM	Zoom (ZM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:59PM	Markets Slide on Bond Option; Q1 Earnings After the Close (Zacks)
05:20PM	Zoom Communications (ZM) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:34PM	Zoom Earnings Top Estimates, Revenue Outlook Edges By Views (Investor's Business Daily)
04:30PM	Zoom stock reacts to Q1 earnings beat, full-year guidance raise (Yahoo Finance Video)
04:13PM	Zoom (NASDAQ:ZM) Exceeds Q1 Expectations, Quarterly Revenue Guidance Slightly Exceeds Expectations (StockStory)
04:05PM	Zoom Communications Reports Financial Results for the First Quarter of Fiscal Year 2026 (GlobeNewswire)
10:56AM	Earnings Data Deluge (Zacks)
10:26AM	Q1 Retailers Report Earnings: TGT Misses, LOW & TJX Beat (Zacks)
May-20-25 08:58PM	Jim Cramer Says Zoom Communications (ZM)'s "Last Quarter Was Actually Pretty Good" (Insider Monkey)
May-19-25 10:59AM	Zoom Gears Up to Post Q1 Earnings: What's in Store for the Stock? (Zacks)
09:15AM	Loading…
May-16-25 09:15AM	Seeking Clues to Zoom (ZM) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
May-15-25 05:15PM	ESS Tech, Inc. (GWH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
10:00AM	Workday (WDAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
May-14-25 10:00AM	Analysts Estimate Zoom Communications (ZM) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	Investors Heavily Search Zoom Communications, Inc. (ZM): Here is What You Need to Know (Zacks)
May-12-25 05:45PM	Zoom Communications (ZM) Gains But Lags Market: What You Should Know (Zacks)
05:25PM	Rapid7 (RPD) Tops Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 03:00PM	Can NOW's Strong Portfolio & Rich Partner Base Push the Stock Higher? (Zacks)
11:05AM	Zoom, ServiceNow plan to integrate Zoom CX with ServiceNow CRM, ITSM (TipRanks)
May-07-25 11:00AM	Zoom and ServiceNow Announce Strategic Integration to Elevate Customer and Employee Experiences (GlobeNewswire)
08:40AM	Unity Software Inc. (U) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-06-25 05:45PM	Zoom Communications (ZM) Stock Moves -0.23%: What You Should Know (Zacks)
12:36PM	RNG Set to Report Q1 Earnings: What's in the Cards for the Stock? (Zacks)
12:36AM	3 Software Stocks Skating on Thin Ice (StockStory)
May-05-25 12:38AM	1 Profitable Stock Worth Your Attention and 2 to Approach with Caution (StockStory)
May-04-25 06:46AM	Zoom Communications: Why I Disagree With Wall Street (Seeking Alpha)
May-01-25 04:05PM	Zoom to Release Financial Results for the First Quarter of Fiscal Year 2026 (GlobeNewswire)
03:39AM	Is Zoom Communications Inc. (ZM) the Most Profitable Growth Stock to Buy Now? (Insider Monkey)
Apr-30-25 05:45PM	Zoom Communications (ZM) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:00AM	Zoom Communications, Inc. (ZM) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-29-25 05:05AM	Q4 Earnings Roundup: Zoom (NASDAQ:ZM) And The Rest Of The Video Conferencing Segment (StockStory)
Apr-28-25 05:50PM	Zoom Communications (ZM) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Apr-25-25 05:09AM	3 Reasons to Avoid ZM and 1 Stock to Buy Instead (StockStory)
Apr-24-25 09:08AM	3 Cash-Producing Stocks That Concern Us (StockStory)
Apr-21-25 05:33PM	Why Zoom Communications Inc. (ZM) Is Among the Best Telehealth Stocks to Buy Now (Insider Monkey)
03:44PM	Zoom: Deep Value Tariff Buy With 35% Net Cash (Seeking Alpha)
Apr-17-25 10:26AM	Zoom Communications price target lowered to $79 from $96 at Morgan Stanley (TipRanks)
Apr-16-25 11:08AM	Should You Buy The New York Times Stock at Its Discounted Price? (Zacks)
09:00AM	Zoom Communications, Inc. (ZM) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
09:00AM	Zoom Workplace for Frontline now available to improve on-shift communications and work management for frontline workers (GlobeNewswire)
Apr-14-25 05:50PM	Zoom Communications (ZM) Outperforms Broader Market: What You Need to Know (Zacks)
Apr-12-25 05:47AM	5 Key Investment Trends To Watch For The Next Decade (Seeking Alpha)
Apr-10-25 09:53AM	This COVID Growth Stock, Down 88% From Its Peak, May Be A Hidden Gem Amid Trump's Tariffs (Motley Fool)
05:00AM	Zacks.com featured highlights Meritage Homes, Zoom, Edison, Super Micro Computer and Coherent (Zacks)
Apr-09-25 08:52AM	5 Stocks With Robust Sales Growth to Buy Amid Tariff Headwinds (Zacks) +7.69%
Apr-07-25 05:50PM	Zoom Communications (ZM) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Apr-04-25 10:42AM	Is Zoom's Expanding AI Integration a Sign to Buy the Stock Now? (Zacks) -7.51%
Apr-03-25 11:50AM	Bumbershoot Holdings 2024 Investor Letter (Seeking Alpha)
Apr-02-25 12:29PM	RingCentral Plunges 28% YTD: Should You Buy the Stock on the Dip? (Zacks)
Apr-01-25 11:32PM	Zoom Communications: Stock Unlikely To Move Upwards If Revenue Doesn't Grow (Seeking Alpha)
05:50PM	Zoom Communications (ZM) Gains But Lags Market: What You Should Know (Zacks)
09:00AM	Investors Heavily Search Zoom Communications, Inc. (ZM): Here is What You Need to Know (Zacks)
Mar-28-25 10:47AM	Those RTO plans? CFOs arent all in. (CFO Dive)
10:47AM	Those return-to-office plans? CFOs arent all in. (CFO Dive)
Mar-27-25 08:47PM	Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update (SeekingAlpha)
12:23PM	Agentic AI Set to Transform Industries in 2025: 4 Stocks to Watch (Zacks)
Mar-26-25 05:45PM	Zoom Communications (ZM) Stock Moves -0.45%: What You Should Know (Zacks)
11:30AM	Zoom (ZM) Up 5.3% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-25-25 05:50PM	Zoom Communications (ZM) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Mar-24-25 08:42AM	Zoom Communications (ZM) Struggled Due to Shift in Consumer Trends And Challenging Macroeconomic Environment (Insider Monkey)
Mar-21-25 04:42PM	Zoom Communications (ZM) Enhances AI Companion with Smart Automation and Customization (InsiderMonkey)
09:01AM	1 Mid-Cap Stock on Our Buy List and 2 to Ignore (StockStory)
05:01AM	The Zacks Analyst Blog Highlights Broadcom, Zoom, NVIDIA and Fortinet (Zacks)
Mar-20-25 12:00PM	Zoom (ZM) Upgraded to Buy: Here's What You Should Know (Zacks)
10:13AM	Here's Why Zoom's AI Evolution Makes ZM Stock Worth Buying in 2025 (Zacks)
10:09AM	4 Tech Stocks Positioned for Strong Growth in the Rest of 2025 (Zacks)
Mar-18-25 09:30AM	Zoom Communications price target lowered to $75 from $85 at Scotiabank (TipRanks)
07:30AM	Zoom Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025 (GlobeNewswire)
Mar-17-25 09:00AM	Zoom debuts new agentic AI skills and agents for Zoom AI Companion (GlobeNewswire)
Mar-12-25 05:53AM	This Cheaply Valued Tech Stock Could Jump 21%, According to Wall Street Analysts. Should You Start Buying It Hand Over Fist? (Motley Fool)
Mar-05-25 03:01PM	Is Zoom Communications Inc. (ZM) the Best Low Beta Tech Stock to Buy According to Analysts? (Insider Monkey)
Feb-28-25 03:45PM	Zoom Communications (ZM) and Mitel Launch Hybrid Cloud Solution for Unified Communications (Insider Monkey)
08:55AM	Zoom Sees AI Momentum as Enterprise Revenue Grows (Motley Fool)
04:04AM	A Look Back at Video Conferencing Stocks Q4 Earnings: 8x8 (NASDAQ:EGHT) Vs The Rest Of The Pack (StockStory)
Feb-27-25 12:50PM	Zoom Communications Inc. (ZM) Reports Steady Growth as AI Companion Adoption Surges (Insider Monkey)
09:00AM	Zoom and Mitel announce rollout of AI-first hybrid communications and collaboration solution (GlobeNewswire)
04:03AM	Q4 Video Conferencing Earnings: Five9 (NASDAQ:FIVN) Impresses (StockStory)
Feb-25-25 07:34PM	Analyst Report: Zoom Communications Inc. (Morningstar Research) -8.48%
02:07PM	Why Zoom (ZM) Shares Are Plunging Today (StockStory)
10:59AM	Zoom Crashes 8% -- Investors Stunned by Weak Outlook Despite AI Boom (GuruFocus.com)

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Subotovsky Santiago	Director	Jun 03 '25	Sale	80.67	2,475	199,663	155,349	Jun 05 07:28 PM
Subotovsky Santiago	Director	May 05 '25	Sale	78.82	2,475	195,087	157,824	May 07 07:26 PM
Subotovsky Santiago	Director	Apr 24 '25	Sale	75.43	2,475	186,684	160,299	Apr 28 07:56 PM
Chadwick Jonathan	Director	Apr 24 '25	Sale	75.03	12,500	937,926	1,514	Apr 28 07:55 PM
Chadwick Jonathan	Director	Apr 15 '25	Sale	72.57	12,500	907,162	1,514	Apr 17 07:10 PM
Bawa Aparna	Chief Operating Officer	Apr 15 '25	Sale	72.59	16,099	1,168,623	1,978	Apr 17 07:09 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Apr 15 '25	Sale	71.91	11,839	851,342	125,529	Apr 17 07:08 PM
Yuan Eric S.	Chief Executive Officer	Apr 14 '25	Sale	72.18	41,121	2,968,229	0	Apr 16 06:28 PM
Aparna Bawa	Officer	Apr 15 '25	Proposed Sale	71.96	16,099	1,158,484		Apr 15 05:02 PM
JONATHAN CHADWICK	Director	Apr 15 '25	Proposed Sale	71.98	25,000	1,799,500		Apr 15 04:30 PM
VELCHAMY SANKARLINGAM	Officer	Apr 15 '25	Proposed Sale	71.91	11,839	851,342		Apr 15 04:04 PM
Eric S. Yuan	Other: Chief Executive Officer	Apr 14 '25	Proposed Sale	71.98	41,121	2,959,890		Apr 14 04:35 PM
Crehan Shane	Chief Accounting Officer	Apr 09 '25	Option Exercise	0.00	7,339	0	13,308	Apr 11 06:37 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Apr 09 '25	Option Exercise	0.00	32,072	0	143,117	Apr 11 06:36 PM
Bawa Aparna	Chief Operating Officer	Apr 08 '25	Option Exercise	0.00	21,392	0	23,370	Apr 10 09:41 PM
Bawa Aparna	Chief Operating Officer	Apr 09 '25	Option Exercise	0.00	11,320	0	23,826	Apr 10 09:41 PM
Yuan Eric S.	Chief Executive Officer	Apr 08 '25	Option Exercise	0.00	68,455	0	68,455	Apr 10 09:37 PM
Yuan Eric S.	Chief Executive Officer	Apr 09 '25	Option Exercise	0.00	15,093	0	48,786	Apr 10 09:37 PM
Subotovsky Santiago	Director	Mar 24 '25	Sale	77.86	2,475	192,702	169,452	Mar 26 08:15 PM
Santiago Subotovsky	Director	Mar 24 '25	Proposed Sale	78.20	9,900	774,180		Mar 24 05:45 PM
Subotovsky Santiago	Director	Dec 04 '24	Sale	82.90	193	16,000	0	Mar 21 08:36 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Mar 09 '25	Option Exercise	0.00	7,031	0	124,791	Mar 11 08:33 PM
Crehan Shane	Chief Accounting Officer	Mar 09 '25	Option Exercise	0.00	3,013	0	8,417	Mar 11 08:28 PM
Yuan Eric S.	Chief Executive Officer	Mar 05 '25	Sale	75.18	91,133	6,851,216	0	Mar 06 07:15 PM
Yuan Eric S.	Chief Executive Officer	Mar 04 '25	Sale	74.98	75,531	5,663,110	0	Mar 06 07:15 PM
Yuan Eric S.	Chief Executive Officer	Feb 04 '25	Sale	86.28	83,332	7,189,667	0	Feb 06 08:14 PM
Yuan Eric S.	Chief Executive Officer	Feb 05 '25	Sale	86.12	83,332	7,176,268	0	Feb 06 08:14 PM
Chadwick Jonathan	Director	Jan 15 '25	Sale	80.33	25,000	2,008,195	1,514	Jan 17 06:53 PM
Bawa Aparna	Chief Operating Officer	Jan 14 '25	Sale	79.15	12,075	955,796	1,978	Jan 16 08:11 PM
Yuan Eric S.	Chief Executive Officer	Jan 13 '25	Sale	79.03	118,036	9,328,255	0	Jan 15 09:04 PM
Yuan Eric S.	Chief Executive Officer	Jan 14 '25	Sale	79.21	83,333	6,601,088	0	Jan 15 09:04 PM
JONATHAN CHADWICK	Director	Jan 15 '25	Proposed Sale	79.20	25,000	1,980,000		Jan 15 04:20 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Jan 09 '25	Option Exercise	0.00	20,751	0	128,577	Jan 13 08:11 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Jan 10 '25	Sale	78.69	10,817	851,170	117,760	Jan 13 08:11 PM
Crehan Shane	Chief Accounting Officer	Jan 09 '25	Option Exercise	0.00	3,565	0	6,816	Jan 13 08:10 PM
Crehan Shane	Chief Accounting Officer	Jan 10 '25	Sale	78.69	1,412	111,104	5,404	Jan 13 08:10 PM
Eric S. Yuan	Other: Chief Executive Officer	Jan 13 '25	Proposed Sale	78.82	534,697	42,144,818		Jan 13 05:37 PM
Shane Crehan	Officer	Jan 10 '25	Proposed Sale	78.69	1,412	111,104		Jan 10 09:51 PM
Velchamy Sankarlingam	Officer	Jan 10 '25	Proposed Sale	78.69	10,817	851,170		Jan 10 09:38 PM
Aparna Bawa	Officer	Jan 10 '25	Proposed Sale	78.69	9,317	733,125		Jan 10 09:16 PM
Bawa Aparna	Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	21,392	0	23,370	Jan 10 09:15 PM
Bawa Aparna	Chief Operating Officer	Jan 10 '25	Sale	78.69	9,317	733,125	14,053	Jan 10 09:15 PM
Yuan Eric S.	Chief Executive Officer	Jan 08 '25	Option Exercise	0.00	68,454	0	68,454	Jan 10 08:39 PM
Yuan Eric S.	Chief Executive Officer	Jan 08 '25	Sale	78.69	33,751	2,655,809	34,703	Jan 10 08:39 PM
Eric S. Yuan	Chief Executive Officer	Jan 10 '25	Proposed Sale	78.69	33,751	2,655,809		Jan 10 08:38 PM
Crehan Shane	Chief Accounting Officer	Dec 09 '24	Option Exercise	0.00	3,013	0	4,802	Dec 11 07:30 PM
Crehan Shane	Chief Accounting Officer	Dec 10 '24	Sale	84.94	1,551	131,740	3,251	Dec 11 07:30 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Dec 09 '24	Option Exercise	0.00	7,030	0	111,444	Dec 11 07:28 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Dec 10 '24	Sale	84.94	3,618	307,309	107,826	Dec 11 07:28 PM
Shane Crehan	Officer	Dec 10 '24	Proposed Sale	84.94	1,551	131,740		Dec 10 09:43 PM
Velchamy Sankarlingam	Officer	Dec 10 '24	Proposed Sale	84.94	3,618	307,309		Dec 10 09:41 PM
Gordon Ritter	Shareholder	Dec 09 '24	Proposed Sale	85.58	41,911	3,586,743		Dec 09 06:55 PM
Yuan Eric S.	Chief Executive Officer	Dec 05 '24	Sale	84.01	83,333	7,000,721	0	Dec 06 08:07 PM
Yuan Eric S.	Chief Executive Officer	Dec 04 '24	Sale	83.50	83,333	6,957,944	0	Dec 06 08:07 PM
Kelly Steckelberg	Officer	Nov 27 '24	Proposed Sale	83.41	414,582	34,580,284		Nov 27 06:48 PM
Yuan Eric S.	Chief Executive Officer	Nov 05 '24	Sale	76.91	178,571	13,734,554	0	Nov 07 07:44 PM
Yuan Eric S.	Chief Executive Officer	Nov 06 '24	Sale	79.65	83,333	6,637,131	0	Nov 07 07:44 PM
Eric S. Yuan	Other: Chief Executive Officer	Nov 05 '24	Proposed Sale	77.75	285,714	22,214,264		Nov 05 05:03 PM
Chadwick Jonathan	Director	Oct 29 '24	Sale	75.04	12,500	937,995	1,514	Oct 31 06:51 PM
JONATHAN CHADWICK	Director	Oct 29 '24	Proposed Sale	73.85	25,000	1,846,250		Oct 29 04:21 PM
Yuan Eric S.	Chief Executive Officer	Oct 22 '24	Sale	72.21	35,714	2,578,983	21,657	Oct 23 06:51 PM
Yuan Eric S.	Chief Executive Officer	Oct 21 '24	Sale	71.45	35,722	2,552,309	57,371	Oct 23 06:51 PM
Eric S. Yuan	Other: Chief Executive Officer	Oct 21 '24	Proposed Sale	72.17	214,292	15,465,454		Oct 21 04:39 PM
Chadwick Jonathan	Director	Oct 14 '24	Sale	68.36	12,500	854,507	1,514	Oct 16 07:41 PM
Bawa Aparna	Chief Operating Officer	Oct 14 '24	Sale	68.59	10,520	721,529	1,978	Oct 16 07:39 PM
Aparna Bawa	Officer	Oct 14 '24	Proposed Sale	71.07	10,520	747,656		Oct 15 11:32 AM
JONATHAN CHADWICK	Director	Oct 14 '24	Proposed Sale	70.68	12,500	883,500		Oct 15 08:02 AM
Sankarlingam Velchamy	Pres. of Engineering & Product	Oct 09 '24	Option Exercise	0.00	20,752	0	114,752	Oct 11 07:21 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Oct 10 '24	Sale	69.51	10,338	718,604	104,414	Oct 11 07:21 PM
Crehan Shane	Chief Accounting Officer	Oct 09 '24	Option Exercise	0.00	3,565	0	3,565	Oct 11 07:15 PM
Crehan Shane	Chief Accounting Officer	Oct 10 '24	Sale	69.51	1,776	123,451	1,789	Oct 11 07:15 PM
Napolitano Janet	Director	Oct 09 '24	Sale	69.39	4,477	310,650	2,984	Oct 11 05:07 PM
Shane Crehan	Officer	Oct 10 '24	Proposed Sale	69.51	1,776	123,451		Oct 10 09:45 PM
Velchamy Sankarlingam	Officer	Oct 10 '24	Proposed Sale	69.51	10,338	718,604		Oct 10 09:43 PM
Bawa Aparna	Chief Operating Officer	Oct 08 '24	Option Exercise	0.00	21,391	0	23,369	Oct 10 09:42 PM
Bawa Aparna	Chief Operating Officer	Oct 08 '24	Sale	68.12	10,871	740,533	12,498	Oct 10 09:42 PM
Steckelberg Kelly	Chief Financial Officer	Oct 08 '24	Option Exercise	0.00	33,217	0	154,578	Oct 10 09:42 PM
Steckelberg Kelly	Chief Financial Officer	Oct 09 '24	Sale	68.12	14,151	963,966	140,427	Oct 10 09:42 PM
Yuan Eric S.	Chief Executive Officer	Oct 08 '24	Option Exercise	0.00	68,453	0	151,547	Oct 10 09:41 PM
Yuan Eric S.	Chief Executive Officer	Oct 09 '24	Sale	68.20	37,206	2,537,494	114,341	Oct 10 09:41 PM
Yuan Eric S.	Chief Executive Officer	Oct 10 '24	Sale	70.60	21,248	1,500,054	93,093	Oct 10 09:41 PM
Eric S. Yuan	Other: Chief Executive Officer	Oct 10 '24	Proposed Sale	69.97	21,248	1,486,723		Oct 10 04:02 PM
Kelly Steckelberg	Officer	Oct 09 '24	Proposed Sale	68.12	14,151	963,966		Oct 09 09:45 PM
Eric S. Yuan	Chief Executive Officer	Oct 09 '24	Proposed Sale	68.12	34,786	2,369,622		Oct 09 09:31 PM
Aparna Bawa	Officer	Oct 09 '24	Proposed Sale	68.12	10,871	740,533		Oct 09 09:30 PM
JANET ANN NAPOLITANO	Director	Oct 09 '24	Proposed Sale	68.32	4,477	305,869		Oct 09 04:18 PM
Crehan Shane	Chief Accounting Officer	Oct 05 '24	Option Exercise	0.00	4,861	0	4,861	Oct 08 08:51 PM
Crehan Shane	Chief Accounting Officer	Oct 07 '24	Sale	69.09	2,478	171,205	2,383	Oct 08 08:51 PM
Crehan Shane	Chief Accounting Officer	Oct 08 '24	Sale	68.30	2,383	162,759	0	Oct 08 08:51 PM
SHANE CREHAN	Officer	Oct 08 '24	Proposed Sale	68.30	2,383	162,759		Oct 08 04:07 PM
Shane Crehan	Officer	Oct 07 '24	Proposed Sale	69.09	353	24,389		Oct 07 08:10 PM
Steckelberg Kelly	Chief Financial Officer	Oct 02 '24	Sale	67.79	8,901	603,436	0	Oct 04 05:40 PM
Steckelberg Kelly	Chief Financial Officer	Sep 18 '24	Sale	66.47	8,901	591,671	0	Sep 20 05:35 PM
Kelley Steckelberg	Affiliate	Sep 18 '24	Proposed Sale	68.11	62,307	4,243,730		Sep 18 05:34 PM
Bawa Aparna	Chief Operating Officer	Sep 10 '24	Sale	66.29	831	55,083	1,978	Sep 12 08:47 PM
Crehan Shane	Chief Accounting Officer	Sep 09 '24	Option Exercise	0.00	3,013	0	3,013	Sep 11 08:24 PM
Crehan Shane	Chief Accounting Officer	Sep 10 '24	Sale	66.87	1,550	103,648	1,463	Sep 11 08:24 PM
Crehan Shane	Chief Accounting Officer	Sep 11 '24	Sale	66.61	1,463	97,450	0	Sep 11 08:24 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Sep 09 '24	Option Exercise	0.00	7,030	0	97,614	Sep 11 08:21 PM
Sankarlingam Velchamy	Pres. of Engineering & Product	Sep 10 '24	Sale	66.87	3,614	241,668	94,000	Sep 11 08:21 PM

VIR

Vir Biotechnology Inc

ZM

Zoom Communications Inc

Upgrade your FINVIZ experience